DEMEI is a premium line of hyaluronic acid-based dermal fillers developed by DKBIO Co., Ltd. in collaboration with EG DONG AN Clinic Network. These fillers use advanced LEDM (Low-Energy Dehydrothermal Crosslinking) technology, achieving a high cross-linking rate of 92% for enhanced stability and longevity. Formulated with non-animal sourced hyaluronic acid at a concentration of 20 mg/mL, DEMEI fillers minimize the risk of allergic reactions. Residual BDDE levels are very low (less than 0.5 ppm), ensuring safety and biocompatibility.